Study of therapeutic effect of different concentrations of imatinib on Balb/c model of cutaneous leishmaniasis

Leishmaniasis, as a tropical and subtropical disease, is endemic in more than 90 countries around the world. Today, cutaneous leishmaniasis (CL) that affects more than 1.5 million people per year lacks a definitive treatment approach. Imatinib is an anticancer drug that inhibits the abnormal functio...

詳細記述

保存先:
書誌詳細
出版年:AIMS Microbiol
主要な著者: Moslehi, Mohsen, Namdar, Fatemeh, Esmaeilifallah, Mahsa, Iraji, Fariba, Vakili, Bahareh, Sokhanvari, Fatemeh, Hosseini, Seyed-Mohsen, Khamesipour, Faham, Sebghatollahi, Zahra, Hejazi, Sayed-Hossein
フォーマット: Artigo
言語:Inglês
出版事項: AIMS Press 2020
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7326727/
https://ncbi.nlm.nih.gov/pubmed/32617447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3934/microbiol.2020010
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料